Your browser doesn't support javascript.
loading
Hesperadin suppresses pancreatic cancer through ATF4/GADD45A axis at nanomolar concentrations.
Zhang, Yixuan; Wu, Jianzhuang; Fu, Yao; Yu, Ranran; Su, Haochen; Zheng, Qisi; Wu, Hao; Zhou, Siqi; Wang, Kun; Zhao, Jing; Shen, Shanshan; Xu, Guifang; Wang, Lei; Yan, Chao; Zou, Xiaoping; Lv, Ying; Zhang, Shu.
Afiliación
  • Zhang Y; Department of Gastroenterology, Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School, No. 321 Zhongshan Road, Nanjing, 210008, Jiangsu, China.
  • Wu J; Nanjing University Institute of Pancreatology, Nanjing, China.
  • Fu Y; Nanjing University Institute of Pancreatology, Nanjing, China.
  • Yu R; State Key Laboratory of Pharmaceutical Biotechnology, School of Life Sciences, Nanjing University, Nanjing, China.
  • Su H; Department of Pathology, Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School, No. 321 Zhongshan Road, Nanjing, 210008, Jiangsu, China.
  • Zheng Q; State Key Laboratory of Pharmaceutical Biotechnology, School of Life Sciences, Nanjing University, Nanjing, China.
  • Wu H; Nanjing University Institute of Pancreatology, Nanjing, China.
  • Zhou S; Department of Gastroenterology, Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing Medical University, Nanjing, China.
  • Wang K; Department of Clinical Laboratory, Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School, No. 321 Zhongshan Road, Nanjing, 210008, Jiangsu, China.
  • Zhao J; Department of Gastroenterology, Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School, No. 321 Zhongshan Road, Nanjing, 210008, Jiangsu, China.
  • Shen S; Nanjing University Institute of Pancreatology, Nanjing, China.
  • Xu G; Nanjing University Institute of Pancreatology, Nanjing, China.
  • Wang L; Department of Gastroenterology, Nanjing Drum Tower Hospital, The Affiliated Hospital of Jiangsu University, Nanjing, China.
  • Yan C; Nanjing University Institute of Pancreatology, Nanjing, China.
  • Zou X; Department of Gastroenterology, Nanjing Drum Tower Hospital, The Affiliated Hospital of Xuzhou Medical University, Nanjing, China.
  • Lv Y; Department of Gastroenterology, Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School, No. 321 Zhongshan Road, Nanjing, 210008, Jiangsu, China.
  • Zhang S; Nanjing University Institute of Pancreatology, Nanjing, China.
Oncogene ; 41(25): 3394-3408, 2022 06.
Article en En | MEDLINE | ID: mdl-35551503
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias Pancreáticas / Indoles Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: Oncogene Asunto de la revista: BIOLOGIA MOLECULAR / NEOPLASIAS Año: 2022 Tipo del documento: Article País de afiliación: China
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias Pancreáticas / Indoles Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: Oncogene Asunto de la revista: BIOLOGIA MOLECULAR / NEOPLASIAS Año: 2022 Tipo del documento: Article País de afiliación: China